From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: All about Optibiotix apart from a few comments on the most despicable MBE out there

By Tom Winnifrith | Thursday 17 March 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I do comment about Julie Meyer’s latest tweet. Suicide is no joking matter and this act alone should see her lose her MBE. But most of this podcast is about events today at Optibiotix (OPTI) whose core businessis not worth MINUS £12 million as Mr Market implies. Ahead of the 24th March FYB! A pedant points out that at 14 mins in I say Optibiotix shareholders will get a distribution of 36-38%of Skinbiotherapeutics – clearly  meant Probiotix. Apologies – long covid strikes again.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 15:55:38